← Back to Search

COAST-AL Intervention for HIV/AIDS (COAST-AL Trial)

N/A

Recruiting

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Over the age of 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 year intervention period

Awards & highlights

COAST-AL Trial Summary

This trial will test a new HIV intervention that includes targeted testing and community-based care in Mobile County, Alabama.

Who is the study for?

This trial is for adults over 18 involved in HIV care in Alabama's Mobile County Health Department area, including medical and outreach staff. For certain parts of the study, individuals over 13 who were tested for HIV post-implementation are eligible. Those unable to consent cannot participate.Check my eligibility

What is being tested?

The COAST-AL intervention being tested includes targeted community-based HIV testing, a Project Connect program for quick linkage to care upon diagnosis, and a Rapid ART Start program to begin treatment swiftly in Alabama.See study design

What are the potential side effects?

Since this trial focuses on implementation strategies rather than medications, traditional side effects aren't applicable. However, participants may experience issues related to service delivery or access.

COAST-AL Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am over 18 years old.

COAST-AL Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 year intervention period

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 year intervention period

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 year intervention period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of zctas with >15% population HIV tested

Time to viral suppression

Secondary outcome measures

Days from diagnosis to initiation of ART

Proportion linked to care within 30 days

COAST-AL Trial Design

1Treatment groups

Experimental Treatment

Group I: COAST-ALExperimental Treatment1 Intervention

This combination intervention includes three CDC evidence based interventions: (1) a data-driven approach to direct Community-based HIV testing to areas with high need, (2) Project Connect to expedite linkage to care at time of diagnosis, (3) and a Rapid ART Start program, all in MCHD jurisdictions in Alabama

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Alabama Department of Public HealthUNKNOWN

University of Alabama at BirminghamLead Sponsor

1,583 Previous Clinical Trials

2,279,914 Total Patients Enrolled

Mobile County Health DeparmentUNKNOWN

Media Library

COAST-AL Clinical Trial Eligibility Overview. Trial Name: NCT05384145 — N/A

HIV/AIDS Research Study Groups: COAST-AL

HIV/AIDS Clinical Trial 2023: COAST-AL Highlights & Side Effects. Trial Name: NCT05384145 — N/A

COAST-AL 2023 Treatment Timeline for Medical Study. Trial Name: NCT05384145 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still eligibility to join this experimental research?

"Sources from clinicaltrials.gov indicate that this research venture is no longer recruiting, having last been updated on September 21st 2022 and initially posted on October 1st 2023. However, there are over two hundred other studies currently accepting enrolment applications at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama

Aadia Rana 2024. "Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05384145.